InvestorsHub Logo

maytepper

10/06/14 3:47 PM

#83440 RE: $heff #83433

$SNSS Sunesis: Despite Primary Endpoint Miss Vosaroxin Still Holds Value, Says Cowen http://www.smarteranalyst.com/2014/10/06/sunesis-despite-primary-endpoint-miss-vosaroxin-still-holds-value-says-cowen/